177 related articles for article (PubMed ID: 2097559)
21. Use of rectal cancer position as a prognostic indicator.
Emslie J; Beart R; Mohiuddin M; Marks G
Am Surg; 1998 Oct; 64(10):958-61. PubMed ID: 9764701
[TBL] [Abstract][Full Text] [Related]
22. Carcinoma of the rectum: factors influencing the prognosis.
Giacchi R; Rogheto M; de Poda D; Lungarotti F
G Chir; 1990 Oct; 11(10):534-8. PubMed ID: 2288841
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological characteristics of mucinous and non-mucinous adenocarcinoma in the colon and rectum in Rajavithi Hospital, Thailand.
Jivapaisarnpong P; Boonthongtho K
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S41-5. PubMed ID: 21717877
[TBL] [Abstract][Full Text] [Related]
24. [Global prognosis and stage classification of colorectal carcinoma].
Terrazas Hontañón JM; Val Bernal JF; Buelta Carrillo L
Rev Esp Oncol; 1985; 32(2):323-41. PubMed ID: 3843465
[TBL] [Abstract][Full Text] [Related]
25. [Colorectal cancer: prognosis after curative surgical treatment without extended elective lymphadenectomy in patients in Dukes C stage].
Secco GB; Fardelli R; Rovida S; Ratto GB; Capponi G; Fabiano F; Motta G
G Chir; 1989 Oct; 10(10):557-61. PubMed ID: 2518293
[TBL] [Abstract][Full Text] [Related]
26. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
[TBL] [Abstract][Full Text] [Related]
27. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.
Vaccaro CA; Im V; Rossi GL; Quintana GO; Benati ML; Perez de Arenaza D; Bonadeo FA
Dis Colon Rectum; 2009 Jul; 52(7):1244-50. PubMed ID: 19571700
[TBL] [Abstract][Full Text] [Related]
28. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.
Rosenberg R; Friederichs J; Schuster T; Gertler R; Maak M; Becker K; Grebner A; Ulm K; Höfler H; Nekarda H; Siewert JR
Ann Surg; 2008 Dec; 248(6):968-78. PubMed ID: 19092341
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report.
Tominaga T; Sakabe T; Koyama Y; Hamano K; Yasutomi M; Takahashi T; Kodaira S; Kato T; Ogawa N
Cancer; 1996 Aug; 78(3):403-8. PubMed ID: 8697383
[TBL] [Abstract][Full Text] [Related]
30. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
31. Clinical and pathological analyses of patients with a family history of colorectal cancer. Registry Committee, Japanese Research Society for Cancer of the Colon and Rectum.
Jpn J Clin Oncol; 1993 Dec; 23(6):342-9. PubMed ID: 8283787
[TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
Li M; Li JY; Zhao AL; Gu J
Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
[TBL] [Abstract][Full Text] [Related]
33. Delay of treatment is associated with advanced stage of rectal cancer but not of colon cancer.
Korsgaard M; Pedersen L; Sørensen HT; Laurberg S
Cancer Detect Prev; 2006; 30(4):341-6. PubMed ID: 16965875
[TBL] [Abstract][Full Text] [Related]
34. Mucinous carcinoma of the colon and rectum in Phramongkutklao Hospital.
Chaleoykitti B
J Med Assoc Thai; 2006 Jan; 89(1):25-8. PubMed ID: 16583577
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic factors in colorectal cancer].
Tominaga T
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2202-8. PubMed ID: 3408254
[TBL] [Abstract][Full Text] [Related]
36. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
37. Biostatistical observation on cancer of the colon and rectum.
Garas J; Politis A; Michaelidis G; Besbeas S; Georgacas G; Evangelou G
Int Surg; 1973 Sep; 58(9):633-4. PubMed ID: 4744422
[No Abstract] [Full Text] [Related]
38. [Prognostic factors of surgically treated colorectal cancer].
Valleur P
Ann Gastroenterol Hepatol (Paris); 1996; 32(2):63-4. PubMed ID: 8737496
[No Abstract] [Full Text] [Related]
39. The impact of spontaneous tumour perforation on outcome following colon cancer surgery.
Abdelrazeq AS; Scott N; Thorn C; Verbeke CS; Ambrose NS; Botterill ID; Jayne DG
Colorectal Dis; 2008 Oct; 10(8):775-80. PubMed ID: 18266887
[TBL] [Abstract][Full Text] [Related]
40. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
